Abnormal haemoglobins: Detection & characterization

Indian Journal of Medical Research

Volumn 134, Issue 10, 2011, Pages 538-546

  Wajcman, Henri ^a   Moradkhani, Kamran ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Haemoglobin variant; Neonatal screening; RBC density; Sickle cell; Thalassaemia

Indexed keywords

ALPHA GLOBIN; DELTA GLOBIN; HEMOGLOBIN; HEMOGLOBIN A2; HEMOGLOBIN C; HEMOGLOBIN D; HEMOGLOBIN E; HEMOGLOBIN F; HEMOGLOBIN H; HEMOGLOBIN S;

ALLELE; ALPHA THALASSEMIA; BETA THALASSEMIA; CAPILLARY ELECTROPHORESIS; CATION EXCHANGE HIGH PERFORMANCE CHROMATOGRAPHY; DNA SEQUENCE; ELECTROSPRAY MASS SPECTROMETRY; HEMOGLOBINOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; ISOELECTRIC FOCUSING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR BIOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; REVIEW;

BETA-THALASSEMIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, CAPILLARY; ERYTHROCYTES; GENETIC VARIATION; HEMOGLOBINOPATHIES; HEMOGLOBINS, ABNORMAL; HUMANS; ISOELECTRIC FOCUSING; PHENOTYPE;

EID: 80455127447     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 2001; 79: 704-12.
2. Riou J, Godart C, Hurtrel D, Mathis M, Bimet C, Bardakdjian-Michau J, et al. Cation-exchange HPLC evaluated for presumptive identification of haemoglobin variants. Clin Chem 1997; 43: 34-9.
3. Joutovsky A, Hadzi-Nesic J, Nardi MA, HPLC retention time as a diagnostic tool for haemoglobin variants and haemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. Clin Chem 2004; 50: 1736-47.
4. Louahabi A, Philippe M, Lali S, Wallemacq P, Maisin D. Evaluation of a new Sebia kit for analysis of haemoglobin fractions and variants on the Capillary system. Clin Chem Lab Med 2006; 44: 340-5.
5. Wajcman H. Electrophoretic Methods for Study of Haemoglobins. In: Nagel RL, editor. Methods in molecular medicine, vol. 82: Haemoglobin disorders: Molecular methods and protocols. Totowa, NJ: Humana Press Inc.; 2003. p. 93-100.
6. Bobhate SK, Gaikwad ST, Bhaledrao T. NESTROFF as a screening test for detection of Beta-thalassaemia trait. Indian J Pathol Microbiol 2002; 45: 265-7.
7. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia a molecular disease. Science 1949; 110: 543-8.
8. Righetti PG. Isoelectric focusing: Theory, methodology and applications. Amsterdam, The Netherlands: Elsevier; 1983.
9. Schneider RG, Barwick RC. Hemoglobin mobility in citrate agar electrophoresis: its relationship to anion binding. Hemoglobin 1982; 6: 199-208.
10. Winter WP, Yodh J. Interaction of human hemoglobin and its variants with agar. Science 1983; 221: 175-8.
11. Van Delft P, Lenters E, Bakker-Verweij M, de Korte M, Baylan U, Harteveld CL, et al. Evaluating five dedicated automatic devices for hemoglobinopathy diagnostics in multi-ethnic populations. Int J Lab Hematol 2009; 31: 484-95.
12. Cotton F, Malaviolle X, Vertongen F, Gulbis B. Evaluation of an automated capillary electrophoresis system in the screening for hemoglobinopathies. Clin Lab 2009; 55: 217-21.
13. Wajcman H, Préhu C, Bardakdjian-Michau J, Promé D, Riou J, Godart C, et al. Abnormal hemoglobins: laboratory methods. Hemoglobin 2001; 25: 169-81.
14. Ducrocq R, Pascaud O, Bévier A, Finet C, Benkerrou M, Elion J. Strategy linking several analytical methods of neonatal screening for sickle cell disease. J Med Screen 2001; 8: 8-14.
15. Bouva MJ, Mohrmann K, Brinkman HB, Kemper-Proper EA, Elvers B, Loeber JG, et al. Implementing neonatal screening for hemoglobinopathies in the Netherlands. J Med Screen 2010; 17: 58-65.
16. Mantikou E, Arkesteijn SG, Beckhoven van JM, Kerkhoffs JL, Harteveld CL, Giordano PC. A brief review on newborn screening methods for hemoglobinopathies and preliminary results selecting beta thalassaemia carriers at birth by quantitative estimation of the HbA fraction. Clin Biochem 2009; 42: 1780-5.
17. ® Neonat Fast Hb device. Clin Biochem 2010; 43: 1345-50.
18. Wajcman H, Riou J. Globin chain analysis: an important tool in phenotype study of hemoglobin disorders. Clin Biochem 2009; 42: 1802-6.
19. Lacombe C, Prome D, Blouquit Y, Bardakdjian J, Arous, N, M'rad A, et al. New results of hemoglobin variant structure determinations by fast atom bombardment mass spectrometry. Hemoglobin 1990; 14: 529-48.
20. Prome D, Deon C, Prome JC, Wajcman H, Galacteros F, Blouquit Y. Use of combined mass spectrometry methods for the characterization of a new variant of human haemoglobin: the double mutant haemoglobin villeparisis b77(EF1) His!Tyr, b80(EF4) Asn>Ser. J Am Soc Mass Spectrom 1996; 7: 163-7.
21. Old JM. DNA diagnosis of hemoglobin mutations. In: Nagel RL, editor. Methods in molecular medicine, vol. 82: Haemoglobin disorders: Molecular methods and protocols. Totowa, NJ: Humana Press Inc.; 2003. p. 101-16.
22. Shih HC, Er TK, Chang TJ, Chang YS, Liu TC, Chang JG. Rapid identification of HBB gene mutations by high-resolution melting analysis. Clin Biochem 2009; 42: 1667-76.
23. Cremonesi L, Ferrari M, Giordano PC, Harteveld CL, Kleanthous M, Papasavva T, et al. An overview of current microarray-based human globin gene mutation detection methods. Hemoglobin 2007; 31: 289-311.
24. Singh SP, Gupta SC. Effectiveness of red cell osmotic fragility test with varying degrees of saline concentration in detecting beta-thalassaemia trait. Singapore Med J 2008; 49: 823-6.
25. Old JM. Screening and genetic diagnosis of hemoglobin 25. disorders. Blood Rev 2003; 17: 43-53.
26. Riou J, Godart C, Mathis M, Hurtrel D, Wajcman H, Préhu C, et al. Evaluation of the Bio-Rad VARIANT_ II HbA2/HbA1C Dual Program for measurement of hemoglobin concentrations and detection of variants. Clin Chem Lab Med 2005; 43: 237-43.
27. Lacerra G, Scarano C, Lagona LF, Testa R, Caruso DG, Medulla E, et al. Genotype-phenotype relationship of the δ-thalassaemia and Hb A(2) variants: observation of 52 genotypes. Hemoglobin 2010; 34: 407-23.
28. Giambona A, Passarello C, Renda D, Maggio A. The significance of the haemoglobin A(2) value in screening for haemoglobinopathies. Clin Biochem 2009; 42: 1786-96.
29. Vichinsky E. Hemoglobin E syndromes. Hematology Am Soc Hematol Educ Program; 2007. p. 79-83.
30. Préhu C, Ducrocq R, Godart C, Riou J, Galactéros F. Determination of Hb F levels: the routine methods. Hemoglobin 1998; 22: 459-67.
31. Rund D, Fucharoen S. Genetic modifiers in hemoglobinopathies. Curr Mol Med 2008; 8: 600-8.
32. Giordano PC, Bakker-Verwij M, Harteveld CL. Frequency of alpha-globin gene triplications and their interaction with beta-thalassaemia mutations. Hemoglobin 2009; 33: 124-31.
33. Pagnier J, Mears JG, Dunda-Belkhodja O, Schaefer-Rego KE, Beldjord C, Nagel RL, et al. Evidence for the multicentric origin of the sickle cell haemoglobin gene in Africa. Proc Natl Acad Sci USA 1984; 81: 1771-3.
34. Babu BV, Leela BL, Kusuma YS. Sickle cell disease amongtribes of Andhra Pradesh and Orissa, India. Anthropol Anz 2002; 60: 169-74.
35. Monplaisir N, Merault G, Poyart C, Rhoda MD, Craescu C, Vidaud M, et al. Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Proc Natl Acad Sci USA 1986; 83: 9363-7.
36. Nagel RL, Daar S, Romero JR, Suzuka SM, Gravell D, Bouhassira E, et al. HbS-Oman heterozygote: a new dominant sickle syndrome. Blood 1998; 92: 4375-82.
37. Feliu-Torres A, Eberle SE, Bragós IM, Sciuccati G, Ojeda MJ, Calvo KL, et al. Hb S-San Martin: a new sickling haemoglobin with two amino acid substitutions [β6(A3)Glu→Val;β105(G7)Leu→Pro] in an Argentinean family. Hemoglobin 2010; 34: 500-4.
38. Danon D, Marikovsky V. Determination of density distribution of red cell population. J Lab Clin Med 1964; 64: 668-74.
39. de Franceschi L, Beuzard Y. Red blood cell indices, cation. content, and membrane cation transports. Hemoglobin 1998; 22: 493-500.
40. Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci 1998; 850: 251-69.
41. Saechan V, Nopparatana C, Nopparatana C, Fucharoen S. Molecular basis and hematological features of hemoglobin variants in Southern Thailand. Int J Hematol 2010; 92: 445-50.
42. Clegg JB, Weatherall DJ, Milner PF. Haemoglobin Constant Spring a chain termination mutant? Nature 1971; 234: 337-40.
43. Wajcman H, Traeger-Synodinos J, Papassotiriou I, Giordano PC, Harteveld CL, Baudin-Creuza V. Unstable and thalassemic alpha chain hemoglobin variants: a cause of Hb H disease and thalassemia intermedia. Hemoglobin 2008; 32: 327-49.
44. Steadman JH, Yates A, Huehns ER. Idiopathic Heinz body. anaemia: Hb-Bristol (beta67 (E11) Val to Asp). Br J Haematol 1970; 18: 435-46.
45. Patrinos GP, Giardine B, Riemer C, Miller W, Chui DHK, Anagnou NP, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucl Acids Res 2004; 32: D537-41.